Ferrer CJE, Sánchez HE, Despaigne SRE, Lavalle GL, Rodríguez GZ

Language: Spanish
References: 12
Page:
PDF size: 336.14 Kb.

ABSTRACT

Introduction: The rapid expansion of COVID-19 caused the World Health Organization, on January 30, 2020, to declare it a health emergency and recognized it as a pandemic on March 11 of the same year.
Objective: To describe the clinical evolution of a hypertensive patient, affected by COVID-19.
Clinical case: This is a 49-year-old patient, hypertensive, affected by COVID-19, treated at the Dr. “Joaquín Castillo Duany” Military Hospital, who during his stay in the intensive care unit, suffered serious complications such as: acute respiratory distress syndrome, pneumonia associated with mechanical artificial ventilation, and pulmonary thromboembolism. The delay in going to the hospital, arterial hypertension, and previous treatment with angiotensin-converting enzyme inhibitors, were among the variables present in this patient, which possibly had a negative impact on his evolution.
Conclusion: With intensive treatment, the ventilatory and anticoagulation strategy used, evolved favorably until his hospital discharge.

REFERENCES

1. OMS. Noticias ONU: Retos de salud urgentes para la próxima década. Ginebra: OMS; 2020. [acceso:18/05/2020]. Disponible en: Disponible en: https://news.un.org/es/story/2020/01/1467872

2. Paules CI, Marston HD, Fauci AS. Coronavirus Infections-More Than Just the Common Cold. JAMA. 2020 [acceso:23/05/2020];323(8):707-8. Disponible en: Disponible en: https://jamanetwork.com/journals/jama/fullarticle/2759815

3. Lippi G, Plebani M. Laboratory abnormalities in patients with COVID-2019 infection. Clin Chem Lab Med. 2020[acceso:23/05/2020];58(7):1-10 . Disponible en: https://doi.org/10.1515/cclm-2020-0198

4. Acosta G , Escobar G, Bernaola G, Alfaro J, Taype W, Marcos C, et al. Caracterización de pacientes con Covid-19 grave atendidos en un hospital de referencia nacional del Perú. Rev Peru Med Exp Salud Pública. 2020 [acceso: 05/06/2020];37(4):1-6. DOI: 10.17843.2020.372.5437

5. Pérez Abreu MR, Gómez Tejeda JJ, Dieguez Guach RA. Características clínico-epidemiológicas de la COVID-19. Rev haban cienc méd. 2020[acceso: 04/06/2020];19(2):e_3254. Disponible en: http://www.revhabanera.sld.cu/index.php/rhab/article/view/3254/2505

6. Guan W, Ni Z, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020 Feb [acceso:29/05/2020]28;1-13. DOI:10.1056/2002032

7. Guo J, Huang Z, Lin L, Lv J. Coronavirus disease 2019 (COVID-19) and cardiovascular disease: a viewpoint on the potential influence of angiotensin-converting enzyme inhibitors/angiotensin receptor blockers on onset and severity of severe acute síndrome coronavirus 2 infection. J Am Heart Assoc. 2020 Apr 07 [acceso:19/05/2020];9(7):e016219. Disponible en: https://www.ahajournals.org/doi/epub/10.1161/JAHA.120.016219

8. Loan AM, Durante López A, Martínez Milla J, Pérez Calvo C, Santos A. Tromboembolia pulmonar en la COVID-19: Cuando nada es lo que parece. Rev Esp Cardiol. 2020. [acceso: 05/06/2020]. DOI:10.1016.2020.04.013

9. Lake MA. What we know so far: COVID-19 current clinical knowledge and research. Clin Med (Lond). 2020[acceso:05/06/2020];20:124-7. DOI: 10.7861.2019

10. Chen N, Zhou M, Dong X, Qu J, Gong R, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020[acceso:09/06/2020];39(10223):507-13. Disponible en: https://www.thelancet.com/pdfs/journals/lancet/PIISO140-6736(20)30211-7.pdf

11. Noya Chaveco ME, Moya González NL. Roca Goderich. Temas de Medicina Interna. 5 ed. La Habana: Editorial Ciencias Médicas; 2017. p.478-95. Tomo 1.

12. Xie Y, Wang X, Yang P, Zhang S. COVID-19 complicated by acute pulmonary embolism. Radiol Cardiothorac Imaging. 2020[acceso:09/06/2020];2(2):e200067. DOI: 10.1148/ryct.2020200067